(Q78408699)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Raffaello Cortesini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Elvira Renna-Molajoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Paola Cinti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Renzo Pretagostini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Eric Ho

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Paola Rossi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Nicole Suciu-Foca Cortesini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1010-1018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppressive drugs: the first 50 years and a glance forward

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Progression of steroid-associated osteoporosis after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Rejection reaction after stopping prednisolone in kidney-transplant recipients taking cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Follow-up of cyclosporine-treated pediatric renal allograft recipients after cessation of prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Long-term outcome of a prospective trial of steroid withdrawal after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Contribution of direct and indirect recognition pathways to T cell alloreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Indirect recognition of donor HLA-DR peptides in organ allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Indirect allorecognition of donor HLA-DR peptides in chronic rejection of heart allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Mechanism of liver allograft rejection: the indirect recognition pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Contribution of the direct and indirect allorecognition pathway to the rejection of liver allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Mechanism of liver allograft rejection: indirect allorecognition

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Indirect allorecognition in heart allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Allospecific T-suppressor cells in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

TCR repertoire of suppressor CD8+CD28- T cell populations

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Detection of T suppressor cells in patients with organ allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Organ allograft recipients develop HLA class I-specific T suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Allospecific human T suppressor cells in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Regulating the immune response to transplants. a role for CD4+ regulatory cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Differentiation of T regulatory cells by immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Certified professionals: CD4(+)CD25(+) suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Distinct mRNA microarray profiles of tolerogenic dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Immunology. Licence to kill.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Strategies for induction of clinical tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2802%2900442-1

7 January 2021

10.1016/S0198-8859(02)00442-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12392853%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference